📊 Score Breakdown
Offering Ability
100
Cash Runway
0
Float Risk
57
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
31%
📉 Score Deterioration
40%
• Score rose 27 points recently (worsening)
💰 Capital Raise
38%
• Active shelf registration ($1000M, 412% of market cap)
• Active ATM program with $24M remaining capacity
💹 Market Data
Market Cap$242.97M
Shares Outstanding46.10M
Float11.64M
Cash$19.62M
Debt$236.80M
Short InterestN/A
🏛 Institutional Holdings
10 institutional holders · 25.76M shares
#1
Entrust Global Partners, LLC
24.22M shares
#2
Third Point, LLC
1.02M shares
#3
Vanguard Group Inc
163.2K shares
+ 7 more holders Sign up free to view →
📉 Short Interest
Short Interest1.93M
Days to Cover5.3
% of Float16.6%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2025
xbrl
XBRL CONVERTIBLE
Dec 31, 2024
424B3
ATM
May 01, 2026
EFFECT
EFFECT
Apr 30, 2026
424B3
ATM
Apr 13, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for FLYX
📊 FLYX FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 FLYX Signal Convergence & Dark Pool Activity — StonkWhisper
📄 FLYX Dilution Risk Analysis — Full In-Depth Report
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.